Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 3 (MTND2P3) is a pseudogene, meaning it is a non-functional genomic DNA sequence similar to the protein-coding gene MT-ND2, which encodes a critical subunit of the mitochondrial respiratory chain complex I. Pseudogenes like MTND2P3 do not encode functional proteins and are typically not involved directly in cellular mitochondrial respiration, electron transport, or any known therapeutic pathways. There is currently no evidence that MTND2P3 functions as a therapeutic target, has a direct biological role, or is associated with disease processes. Some studies have noted changes in pseudogene expression (including other MT-ND2 pseudogenes) in disease contexts such as neurodegeneration, but the precise functional importance, if any, of MTND2P3 remains unknown[4]. Key clarifications and accuracy notes: - MTND2 (without "P" or a pseudogene label) is a functional gene involved in mitochondrial complex I and is associated with numerous diseases, including mitochondrial disorders and neurodegenerative diseases[1][2]. - MTND2 pseudogenes (such as MTND2P3) are not protein-coding and do not act as canonical therapeutic targets, receptors, enzymes, or transporters[4]. - Most published research does not describe individual MTND2 pseudogenes as having a validated molecular or therapeutic role[4]. - There are no known drugs, clinical biomarkers, or safety issues specifically relevant to MTND2P3[4]. Summary judgment: MT-ND2 pseudogene 3 (MTND2P3) does not meet the criteria for a canonical drug target and should not be treated as a receptor, enzyme, or relevant molecular entity for therapeutic intervention or drug discovery. Its name is correctly formed, but as a pseudogene, it has no known biological or therapeutic function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 3 (MTND2P3).